Processing your payment...
Please do not close your browser.

Insulin Injection Pen Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: BD, Ypsomed Holding, Dongbao, Owen Mumford

01 Aug, 2022 | 160 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

The Insulin Injection Pen Market size was valued at US$ 30,605 million in 2021 and is expected to increase to US$ 40,968.4 million by 2027, at a CAGR of 4.9% from 2022 to 2027.



Insulin Injection Pen Market Overview



Insulin pens are insulin administration devices used by diabetic individuals. Insulin users use insulin pens frequently because they are simple to use and administer insulin accurately. Both time logs and insulin dosages can be recorded using the pen. Smart insulin pens were created with the intention of preventing unnecessary dosages, maintaining a systematic record of dosage, and converting dosage data into computer-based reports. The main driving factors are the rising incidence of diabetes, increased awareness of needlestick injuries, diabetes treatments and monitoring for improved disease management, the explosion in connected medical device use, and expanding R&D efforts. The market is anticipated to grow as a result of rising needlestick injury awareness. The world market for insulin pens is anticipated to increase significantly due to the exponentially rising number of diabetic patients. Additionally, an increase in government spending on diabetes is anticipated to usher in new technologies and treatments for slowing the diabetes epidemic's global spread. The surge in the adoption of connected devices and accessories to help people using insulin pens is expected to boost the market.




Industry News and Updates:



Nov. 12, 2020: Medtronic Launches InPen™ with Real-Time Guardian™ Connect CGM Data -- the First Integrated Smart Insulin Pen for People with Diabetes on MDI--

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of InPen™ integrated with real-time1 Guardian Connect™ CGM data. InPen is the first and only FDA-cleared smart2 insulin pen on the market for people on multiple daily injections (MDI). This integrated system now provides real-time glucose readings alongside insulin dose information giving users everything they need to manage their diabetes in one view. Rather than switching between apps, users have the ability to see all their information in real-time, in one view — making it easier to make smarter dosing decisions to manage their sugar levels.



What are the major Applications, Types and Regions for Insulin Injection Pen Market?



Market is segmented based on the type, applications, companies and regions.



By Type, it is segmented into




  • Disposable Insulin Injection Pen

  • Reusable Insulin Injection Pen



By Application, it is segmented into




  • Hospital & Clinic

  • Retail Pharmacies

  • Online



Insulin Injection Pen Market Regional Analysis



Due to the higher prevalence of diabetes and increased healthcare spending for treating diabetes, North America is anticipated to lead the global market for insulin pens during the forecast period. Furthermore, it is anticipated that improvements in insulin pen technology may accelerate their uptake in North America. The gradual transition of patients toward self-care instead of dependency is expected to cause Europe to experience a significant CAGR. Due to its larger patient base of diabetes patients, Asia Pacific is anticipated to see a CAGR that is relatively higher. Additionally, during the projected period, it is anticipated that the region's rising usage of insulin pens would be a result of leading market players' aggressive market penetration efforts.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Insulin Injection Pen Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Insulin Injection Pen Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Insulin Injection Pen Market report scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2027 CAGR



CAGR of 4.9% over the forecast period (2022-2027)



By Type




  • Disposable Insulin Injection Pen

  • Reusable Insulin Injection Pen



By Application




  • Hospital & Clinic

  • Retail Pharmacies

  • Online



By Companies



BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee, Delfu, NovoNordisk A/S, Sanofi, Eli Lilly, Diamesco Co., Ltd., BigFoot Biomedical, Inc, Medtronic plc, Emperra GmbH E-Health Technologies, DUKADA Aps



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



160



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Key Takeaways from this Insulin Injection Pen Market Report




  • Evaluate Insulin Injection Pen market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.

  • Analyze the sales and distribution channels across geographies to enhance top-line revenues.

  • Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Insulin Injection Pen market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.



Frequently Asked Questions



What is the growth rate of Insulin Injection Pen Market?



The Insulin Injection Pen Market is growing at a CAGR of 4.9% over the next 5 years.



Who are the key players in Insulin Injection Pen Market?



BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee, Delfu, NovoNordisk A/S, Sanofi, Eli Lilly, Diamesco Co., Ltd., BigFoot Biomedical, Inc, Medtronic plc, Emperra GmbH E-Health Technologies, DUKADA Aps



What are the significant types of Insulin Injection Pen Market?



Disposable Insulin Injection Pen, Reusable Insulin Injection Pen



What are the major end-use applications of Insulin Injection Pen Market?



Hospital & Clinic, Retail Pharmacies, Online



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.


  1. INTRODUCTION

    1. MARKET DEFINITION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMELINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL INSULIN INJECTION PEN MARKET BY TYPE

    3. GLOBAL INSULIN INJECTION PEN MARKET BY APPLICATION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR INSULIN INJECTION PEN



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    3. OPPORTUNITIES

      1. INSULIN INJECTION PEN GROWTH

      2. APPLICATION OF INSULIN INJECTION PEN



    4. IMPACT OF COVID 19



  5. GLOBAL INSULIN INJECTION PEN MARKET, BY TYPE

    1. INTRODUCTION

    2. DISPOSABLE INSULIN INJECTION PEN

    3. REUSABLE INSULIN INJECTION PEN



  6. GLOBAL INSULIN INJECTION PEN MARKET, BY APPLICATION

    1. INTRODUCTION

    2. HOSPITAL & CLINIC

    3. RETAIL PHARMACIES

    4. ONLINE



  7. GLOBAL INSULIN INJECTION PEN MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. BD

      2. YPSOMED HOLDING

      3. DONGBAO

      4. OWEN MUMFORD

      5. GANLEE

      6. DELFU

      7. NOVONORDISK A/S

      8. SANOFI

      9. ELI LILLY

      10. DIAMESCO CO., LTD.

      11. BIGFOOT BIOMEDICAL, INC

      12. MEDTRONIC PLC

      13. EMPERRA GMBH E-HEALTH TECHNOLOGIES

      14. DUKADA APS





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 9
  • 3M